InvestorsHub Logo
icon url

XenaLives

09/28/18 9:08 AM

#167086 RE: Kentucky123 #167085

I wouldn't take $1000 --- I want Anavex to develop and control this drug, not Big Pharma.

icon url

Investor2014

09/28/18 9:09 AM

#167087 RE: Kentucky123 #167085

If you mean buyout at this point, I think I would be quite disappointed with $20. If the $AVXL reach $20 this year for example, I would sell enough to make my current position FOC, which would leave healthy number of shares to mushroom.
icon url

BAR123

09/28/18 9:10 AM

#167088 RE: Kentucky123 #167085

Right now 50. Takes all risk out and gives me 3.5 million. 6-12 months if we get some very positive news 100.
icon url

BAR123

09/28/18 9:11 AM

#167089 RE: Kentucky123 #167085

Keep in mind 50 is only a 2.5 B market cap.
icon url

bennyboy1

09/28/18 10:44 AM

#167103 RE: Kentucky123 #167085

Kentucky123 - I agree at the present time Anavex should be worth $20 per share. However, I will state emphatically for what we have, it would be a HUGE MISTAKE to bow out at $20 , for what lies ahead in possible success for many indications, with success this will definitely be in the 100's and maybe a lot more over time. I am in it to reap the harvest and see the beauty of helping MILLIONS thruout the WORLD!!!!!!